Gynecology Medical Lasers Global Market Report 2024

The gynecology medical lasers market size has grown exponentially in recent years. It will grow from $0.31 billion in 2023 to $0.45 billion in 2024 at a compound annual growth rate (CAGR) of 44.7%. The growth observed in the historical period can be attributed to several factors. These include the increasing incidence of gynecological cancers, a rise in cosmetic gynecology procedures, growing disposable incomes, and an increasing focus on preventive healthcare.

The gynecology medical lasers market size is expected to see exponential growth in the next few years. It will grow to $1.72 billion in 2028 at a compound annual growth rate (CAGR) of 39.5%. The anticipated growth in the forecast period can be attributed to several factors. These include an aging population and increased focus on menopause management, rising awareness of gynecological health, the global expansion of gynecological services, the integration of telemedicine, and the adoption of minimally invasive procedures. Some significant trends expected in the forecast period include the development of customized treatment plans, non-surgical gynecological solutions, approaches to enhance fertility, the restoration of the vaginal microbiome, and advancements in endometrial ablation techniques.

The increasing prevalence of obesity is poised to be a driving factor for the gynecology medical lasers market. Women who are overweight or obese face a greater likelihood of experiencing gynecological disorders. This population has an elevated risk of reproductive health issues, including infertility, reduced conception rates, higher rates of miscarriage, and an increased susceptibility to pregnancy complications. Their reproductive outcomes are less favorable, both in natural conception and in assisted reproduction methods. The growing global trend of obesity among women is contributing to increased demand for gynecological treatments, thereby stimulating the gynecology medical lasers market.

The gynaecology medical lasers market, as discussed in this report, is categorized by product type, including CO2 laser, KTP-argon laser, and Nd:YAG laser. The CO2 laser is particularly useful for the precise removal of thin layers of skin, causing minimal damage to surrounding tissues. These lasers find applications in procedures like colposcopy, laparoscopy, and hysteroscopy, which are conducted in various medical settings, including hospitals, specialized clinics, ambulatory surgical centers, and medical facilities.

The gynecology medical lasers market research report is one of a series of new reports that provides gynecology medical lasers market statistics, including gynecology medical lasers industry global market size, regional shares, competitors with a gynecology medical lasers market share, detailed gynecology medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the gynecology medical lasers industry. This gynecology medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increasing demand for gynecological treatment is poised to drive the growth of the gynecology medical laser market in the coming years. Gynecological treatment involves addressing health issues that affect a woman's reproductive organs, which can include conditions such as endometriosis, fibroids, vaginal atrophy, and others. Gynecology medical lasers play a significant role in treating these gynecological disorders. For example, as of March 2021, the Health Resources and Services Administration (HRSA) reported that there would be a projected shortage of 5,170 full-time equivalent (FTE) OB-GYNs (obstetrics and gynecology) by 2030 in the United States. The demand for OB-GYNs is expected to grow from 50,850 to 52,660 (4%) by 2030. Hence, the increasing prevalence of gynecological conditions is a key driver for the expansion of the gynecology medical laser market.

The high expenses associated with gynecology lasers are a significant challenge for patients worldwide, particularly in developing nations. There is a growing need to control costs and demonstrate the value of medical procedures. Political uncertainties and ongoing economic pressures in many countries are casting doubt on the long-term sustainability of public healthcare funding. While carbon dioxide lasers are the most commonly used systems in gynecology, their primary applications involve treating conditions of the uterine cervix, vagina, vulva, or perineum. However, their notable drawback is their high cost. For example, CO2 laser therapy typically exceeds $500 per treatment, necessitating an initial course of three treatments, followed by annual treatments. As a result, the elevated expense of gynecology laser treatments, combined with a shortage of skilled technicians in developing nations, is limiting the demand for such lasers and affecting the growth of the gynecology lasers market.

Manufacturers of gynecology medical lasers are making ongoing investments in technologies to expedite the diagnosis and enhance the efficiency of treating gynecological conditions. These technological advances encompass new wavelengths, more durable equipment setups, cost-effective systems, and other innovations that are integrated with minimally invasive procedures. An example of this is the FDA's clearance for the utilization of the Dynamis PRO laser system in gynecology and genitourology, which incorporates two complementary wavelengths to provide rapid and precise treatments. This commitment to technological advancement is driving progress in the field of gynecology medical lasers.

In September 2021, Boston Scientific, a US-based medical device company, completed the acquisition of Lumenis' surgical business for $1.1 billion. This strategic acquisition will facilitate Boston Scientific's global expansion and accelerate its growth in the European and Asian markets. It will also involve the integration of Lumenis' laser portfolio, including the innovative Moses technology, with Boston Scientific's leading services in kidney stone care and benign prostatic hyperplasia. Lumenis, based in Israel, is renowned for its laser products used in various gynecological treatments.

Major companies operating in the gynecology medical lasers market include Quanta System S.p.A, Cynosure Inc., Biolitec AG, Boston Scientific Corporation, DEKA Medical Inc., Limmer Laser GmbH, Linline Medical Systems LLC., Fotona d.d., GIGAA Laser Group, LISA laser products GmbH, Lumenis Ltd., Asclepion Laser Technologies GmbH, Medelux LLC., Alma Lasers Ltd., NeoLaser LLC., BTL Industries Inc., INTERmedic S.A., Jena Surgical GmbH, Cutera Inc., Sciton Inc., Syneron Candela LLC., Lutronic Corporation, Merz Aesthetics Inc., New Star Lasers Inc., Palomar Medical Technologies Inc., Sharplan Lasers Inc., Solta Medical Inc., SpectraMedi LLC, Venus Concept Ltd., Viora Ltd., Zeltiq Aesthetics Inc., Zimmer MedizinSysteme GmbH, Baltic Lasers UAB

North America was the largest region in the gynecology medical lasers market in 2023. Asia-Pacific was the second-largest region in the gynecology medical lasers market report. The regions covered in the gynecology medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the gynecology medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The gynecology medical lasers market consists of sales of instruments that include Nd: YAG, neodymium, and potassium-titanyl-phosphate (KTP). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.